All times listed are in Eastern Time.

Sunday, October 12, 2025

1:30 – 3:30 PM

CONCURRENT WORKSHOP 1

Workshop on Bacteriophage Clinical Trial Design and Regulatory Approaches for Bacteriophage Approval

Three presentations on clinical trial designs for bacteriophage therapy targeting antimicrobial-resistant and mycobacterial infections, with attention to regulatory considerations for treatment approval. It will include a discussion and Q&A session, allowing for an interactive exchange of ideas and insights.

Convener: Constance A. Benson, MD, University of California San Diego, USA

1:30 – 1:40 PM

Welcome and Introduction

1:40 – 2:05 PM

Considerations for Clinical Trials in Bacteriophages
Vance G. Fowler, MD, Duke University, Durham, NC, USA

2:05 – 2:15 PM

Q-and-A

2:15 – 2:40 PM

Practical Considerations for Clinical Trial Design and Analysis of Mycobacteriophage Treatment of NTM: The Design of the POSTSTAMP Trial
Jerry A. Nick, MD, National Jewish Health, Denver, CO, USA

2:40 – 2:50 PM

Q-and-A

2:50 – 3:15 PM

Regulatory Considerations and Data Update for Development and Clinical Use for Phage-Based Antimicrobials
Cara R. Fiore, PhD, United States Food and Drug Administration, Silver Spring, MD, USA, and Timothy Brennan, MD, PhD, United States Food and Drug Administration, Silver Spring, MD, USA

3:15 – 3:25 PM

Q-and-A

3:25 – 3:30 PM

Closing Remarks

1:30 – 3:30 PM

CONCURRENT WORKSHOP 2

Preclinical Models

Three presentations on bacteriophage preclinical models evaluating the safety and efficacy of bacteriophage therapy prior to clinical trials. It will include a discussion and Q&A session, allowing for an interactive exchange of ideas and insights.

Convener: Paul L. Bollyky, MD, Stanford University, CA, USA

1:30 – 1:40 PM

Welcome and Introduction

1:40 – 2:05 PM

Mycobacteriophage in Animal Models
Sasha Akins, PhD, Seattle Children’s Research Institute, WA, USA

2:05 – 2:15 PM

Q-and-A

2:15 – 2:40 PM

Pulmonary Phage Therapy: Lessons From the Murine Model
Laurent Debarbieux, PhD, Institut Pasteur, Paris, France

2:40 – 2:50 PM

Q-and-A

2:50 – 3:15 PM

Caenorhabditis elegans as a Model System for Phage Biology
Patrick Secor, PhD, Montana State University, Bozeman, MT, USA

3:15 – 3:25 PM

Q-and-A

3:25 – 3:30 PM

Closing Remarks

3:30 – 4:00 PM

BREAK

4:00 – 5:30 PM

OPENING SESSION

4:00 – 4:10 PM

Opening Remarks from the Chairs
Graham F. Hatfull, PhD, University of Pittsburgh, PA, USA
Robert T. Schooley, MD, University of California San Diego, CA, USA

4:10 – 4:40 PM

Evolution of Antiviral Immunity
Philip J. Kranzusch, PhD, Harvard Medical School, Cambridge, MA, USA

4:40 – 4:50 PM

Q-and-A

4:50 – 5:20 PM

Phage Therapy From Bench to Bedside, and Back Again
Daria Van Tyne, PhD, University of Pittsburgh, PA, USA

5:20 – 5:30 PM

Q-and-A

5:30 – 5:45 PM

BREAK

5:45 – 8:00 PM

WELCOME RECEPTION

Monday, October 13, 2025

8:30 – 10:05 AM

MORNING SYMPOSIUM

The Bacteriophage Landscape: Diversity and Evolution In Vitro and In Vivo

Three presentations focusing on bacteriophage diversity, the changing nature of bacteriophages, and the hidden reservoir of bacteriophages. It will include a discussion and Q&A session, allowing for an interactive exchange of ideas and insights.

Conveners: Michael T. Laub, PhD, Massachusetts Institute of Technology, Cambridge, MA, USA, and Daria Van Tyne, PhD, University of Pittsburgh, PA, USA

8:30 – 8:35 AM

Introduction

8:35 – 8:55 AM

Diversity of Microviruses: What We Know and What We Don’t Know
Paul Kirchberger, PhD, Oklahoma State University, Stillwater, OK, USA

8:55 – 9:05 AM

Q-and-A

9:05 – 9:25 AM

Phage Evolution in Vitro and In Vivo
Paul E. Turner, PhD, Yale University, New Haven, CT, USA

9:25 – 9:35 AM

Q-and-A

9:35 – 9:55 AM

Prophages: The Hidden Defense Reservoir
Karen Maxwell, PhD, University of Toronto, Canada

9:55 – 10:05 AM

Q-and-A

10:05 – 10:20 AM

BREAK

10:20 – 12:30 PM

CONCURRENT ORAL ABSTRACT SESSION 1

Bacteriophage Biology

Conveners: Jonathan Iredell, University of Sydney, Australia, and Karen Maxwell, University of Toronto, Canada

10:20 – 10:45 AM

New Views of Phage Tail Assembly and Disassembly
Alan Davidson, PhD, University of Toronto, Canada

10:45 – 10:50 AM

Q-and-A

10:50 AM – 12:30 PM

ORAL ABSTRACTS

The oral abstract session will include 7 presentations of 10 minutes each, that focuses on new research, each shedding light on different aspects of bacteriophage research and applications. There will be 2 question and answer segments of 10 minutes each, 1 after the first 3 speakers and the second after the remaining 4 speakers.

10:20 – 12:30 PM

CONCURRENT ORAL ABSTRACT SESSION 2

Clinical Applications of Bacteriophages

Conveners: Constance A. Benson, MD, and Gina A. Suh, MD, Mayo Clinic, Rochester, MN, USA

10:20 – 10:45 AM

Assessment of Phage Susceptibility Testing Reproducibility and Agreement Between Methods
Robin Patel, MD, Mayo Clinic, Rochester, MN, USA

10:45 – 10:50 AM

Q-and-A

10:50 AM – 12:30 PM

ORAL ABSTRACTS

The oral abstract session will include 7 presentations of 10 minutes each, that focuses on new research, each shedding light on different aspects of bacteriophage research and applications. There will be 2 question and answer segments of 10 minutes each, 1 after the first 3 speakers and the second after the remaining 4 speakers.

12:30 – 2:00 PM

LUNCH

2:00 – 3:45 PM

POSTER SESSION

Poster Abstract Sessions comprise the majority of scientific information presented at the Conference on Bacteriophages, including topics that range from Bacteriophage Structure and Assembly, Evolution, and Engineering to Clinical Trials, Susceptibility Testing, and Host/Immune Responses. Presenters of Poster Abstracts who attend the Conference on Bacteriophages in-person will be assigned to stand at their respective boards, organized by topic. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the Conference on Bacteriophages website and other electronic means (access is restricted to registered Bacteriophage attendees during the conference).

3:45 – 4:00 PM

BREAK

4:00 – 5:35 PM

AFTERNOON SYMPOSIUM

Lessons from the Clinic: Exploiting Bacteriophage Biology to Enhance Success

Three presentations focusing on the design and implementation of a 3-phage cocktail for precision therapy, current challenges in the treatment of biofilm-associated infections, and innovative delivery methods and treatments for bacteriophage therapy in respiratory infections. The symposium will include a discussion and Q&A session, allowing for an interactive exchange of ideas and insights.

Conveners: Cara R. Fiore, PhD, United States Food and Drug Administration, Silver Spring, MD, USA, and Gina A. Suh, MD, Mayo Clinic, Rochester, MN, USA

4:00 – 4:05 PM

Introduction

4:05 – 4:25 PM

Phage-Induced Immunity
Anthony Maresso, PhD, Baylor College of Medicine, Houston, TX, USA

4:25 – 4:35 PM

Q-and-A

4:35 – 4:55 PM

Phages vs. Biofilms: Advancing Phage Therapy for Complex Prosthetic Joint Infections due to Staphylococci
Tristan Ferry, MD, PhD,
University Lyon, France

4:55 – 5:05 PM

Q-and-A

5:05 – 5:25 PM

Innovating Phage Therapy for Respiratory Infections
Jonathan Koff, MD, Yale University, New Haven, CT, USA

5:25 – 5:35 PM

Q-and-A

Tuesday, October 14, 2025

8:30 – 10:05 AM

MORNING SYMPOSIUM

Bacteriophage Resistance, Synergy, Tradeoffs: Mechanisms and Consequences

Three presentations focusing on the diversity of defense and counter-defense systems, examining bacteriophage virulence and host resistance, and discussing the mechanisms of bacterial sensing of bacteriophage attacks. The symposium will include a discussion and Q&A session, allowing for an interactive exchange of ideas and insights.

Conveners: Joseph Bondy-Denomy, PhD, University of California San Francisco, USA, and Britt Koskella, PhD, University of California Berkeley, USA

8:30 – 8:35 AM

Introduction

8:35 – 8:55 AM

Exploiting the Features of Mobile Genetic Elements to Identify Antiphage Defenses
Breck Duerkop, PhD, University of Colorado, Anschutz Medical Campus, Aurora CO, USA

8:55 – 9:05 AM

Q-and-A

9:05 – 9:25 AM

Fellowship of the Phage: The Interplay of Microbial Communities and Bacteriophages
Meaghan Castledine, PhD, University of Exeter, Penryn Campus, England, UK

9:25 – 9:35 AM

Q-and-A

9:35 – 9:55 AM

Mapping the Landscape of Anti-Phage Defense Systems
Michael T. Laub, PhD, Massachusetts Institute of Technology, Cambridge, MA, USA

9:55 – 10:05 AM

Q-and-A

10:05 – 10:20 AM

BREAK

10:20 – 12:30 PM

ORAL ABSTRACT SESSION

Bacteriophage Structure, Synthesis, and Engineering

Conveners: Jose R. Penades, PhD, Imperial College London, and Paul Turner, PhD, Yale University, New Haven, CT, USA

10:20 – 10:45 AM

Integrating Phage Biology and Therapeutic Potential
Martha R. J. Clokie, PhD, University of Leicester, United Kingdom

10:45 – 10:50 AM

Q-and-A

10:50 AM – 12:30 PM

ORAL ABSTRACTS

The oral abstract session will include 7 presentations of 10 minutes each, that focuses on new research, each shedding light on different aspects of bacteriophage research and applications. There will be 2 question and answer segments of 10 minutes each, 1 after the first 3 speakers and the second after the remaining 4 speakers.

12:30 – 2:00 PM

LUNCH

2:00 – 3:45 PM

POSTER SESSION

Poster Abstract Sessions comprise the majority of scientific information presented at the Conference on Bacteriophages, including topics that range from Phage Structure and Assembly, Evolution, and Engineering to Clinical Trials, Susceptibility Testing, and Host/Immune Responses. Presenters of Poster Abstracts who attend the Conference on Bacteriophages in-person will be assigned to stand at their respective boards, organized by topic. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the Conference on Bacteriophages website and other electronic means (access is restricted to registered Bacteriophage attendees during the conference).

3:45 – 4:00 PM

BREAK

4:00 – 5:35 PM

AFTERNOON SYMPOSIUM

Bacteriophage Engineering, Synthetic Biology, and Advancing Therapeutic Utility

Three presentations focusing on assembly and rebooting of synthetic phage genomes, high-throughput functional analyses, and the integration of AI and machine learning for predictive bacteriophage therapy. The symposium will include a discussion and Q&A session, allowing for an interactive exchange of ideas and insights.

Conveners: Paul L. Bollyky, MD, Stanford University, CA, USA, and Jonathan Iredell,University of Sydney, Australia

4:00 – 4:05 PM

Introduction

4:05 – 4:25 PM

Synthetic Phage Genomes: Assembly and Rebooting
Erica Hartmann, PhD, Northwestern University, Evanston, IL, USA

4:25 – 4:35 PM

Q-and-A

4:35 – 4:55 PM

Systematic High-Throughput Characterization of Phage-Host Interactions to Build Predictive Models of Phage Susceptibility
Vivek Mutalik, PhD, Lawrence Berkeley National Lab, CA, USA

4:55 – 5:05 PM

Q-and-A

5:05 – 5:25 PM

Predictive Phage Therapy: The Use of Machine Learning to Help Develop Effective Phage Interventions
David Gally, PhD, University of Edinburgh, Scotland

5:25 – 5:35 PM

Q-and-A

Last Modified: Sep 22, 2025 @ 9:01 AM